(Q68712510)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

title

The relationship between diuretics and serum cholesterol in Hypertension Detection and Follow-up Program participants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

3

Borhani NO

0 references

author name string

Williams WR

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

Schneider KA

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

Schnaper HW

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

Slotkoff LM

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

Ellefson RD

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

publication date

1 September 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Preventive Medicine

26 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

page(s)

248-255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

Increase in serum-lipids during treatment of hypertension with chlorthalidone

26 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Elevation of serum lipid levels during diuretic therapy of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Influence of hydrochlorothiazide on the plasma levels of triglycerides, total cholesterol and HDL-cholesterol in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Effects of diuretics on plasma lipoproteins in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Possible metabolic side effects of beta-adrenergic blocking drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Diuretics and serum-cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

The effect of oral hydralazine on circulating human cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Effect of chronic administration of propranolol on lipoprotein composition

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Long-term Effect of Sotalol on Plasma Lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Metabolic consequences of atenolol and propranolol in treatment of essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Effect of propranolol and prazosin on blood lipids. The Oslo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Chlorthalidone and serum cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

The effect of spironolactone and thiabutazide on serum-uric acid and lipid levels in patients with gout and in healthy persons

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Overweight and hypertension. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Influence of race, sex and weight on blood pressure behavior in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

Changes in Plasma and Extracellular Fluid Volumes in Patients with Essential Hypertension During Long-Term Treatment with Hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipids.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2818%2931314-X

7 January 2021

10.1016/S0749-3797(18)31314-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3453187%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference